Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades
Esserman, Laura J., Yau, Christina, Thompson, Carlie K., van 't Veer, Laura J., Borowsky, Alexander D., Hoadley, Katherine A., Tobin, Nicholas P., Nordenskjöld, Bo, Fornander, Tommy, Stål, Olle, Benz,Language:
english
Journal:
JAMA Oncology
DOI:
10.1001/jamaoncol.2017.1261
Date:
June, 2017
File:
PDF, 441 KB
english, 2017